Sutro Biopharma, Inc. (NASDAQ:STRO) Receives $6.11 Consensus Target Price from Analysts
Shares of Sutro Biopharma, Inc. (NASDAQ:STRO – Get Free Report) have been given an average recommendation of “Hold” by the eight analysts that are covering the firm, MarketBeat Ratings reports. One equities research analyst has rated the stock with a sell rating, five have assigned a hold rating and two have issued a buy rating […]
Shares of Sutro Biopharma, Inc. (NASDAQ:STRO – Get Free Report) have been given an average recommendation of “Hold” by the eight analysts that are covering the firm, MarketBeat Ratings reports. One equities research analyst has rated the stock with a sell rating, five have assigned a hold rating and two have issued a buy rating […]
